Fundraising Fox

Replicate Bioscience

San Diego, US · Founded 2021 · Delaware corporation · 23 employees on LinkedIn · 1 known investors

Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.

Founders & leadership

Replicate Bioscience was founded in 2021 by Nathaniel Wang, Andy Geall, Herbert Kim Lyerly, and Zachary Hartman.

NW
Nathaniel WangCo-founder
AG
Andy GeallCo-founder
HK
Herbert Kim LyerlyCo-founder
ZH
Zachary HartmanCo-founder
JY
Joseph YanchikNamed on SEC filing

Board

SH
Seth HarrisonBoard director
ME
Michael EhlersinCo-Founder and Board MemberVenture Partner at Apple Tree Venture Management Llc

Investors · 1

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2021

$20MraisedMar 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nathaniel WangExecutive Officer, Director
  • Seth HarrisonDirector
  • Joseph YanchikDirector
  • Michael EhlersExecutive Officer, Director
Offering amount
$53M
Amount sold
$20M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Replicate Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Replicate Bioscience do?
Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.
Who founded Replicate Bioscience?
Replicate Bioscience was founded by Nathaniel Wang, Andy Geall, Herbert Kim Lyerly, Zachary Hartman in 2021.
Who are Replicate Bioscience's investors?
Replicate Bioscience's investors include ATP.
How much funding has Replicate Bioscience raised?
Replicate Bioscience has disclosed $20M raised across 1 round.
Where is Replicate Bioscience headquartered?
Replicate Bioscience is headquartered in San Diego, US.